Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2

The outbreak of the coronavirus disease 2019 caused by the severe acute respiratory syndrome coronavirus 2 triggered a global pandemic where control is needed through therapeutic and preventive interventions. This study aims to identify natural compounds that could affect the fusion between the vira...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohishi, Tomokazu, Hishiki, Takayuki, Baig, Mirza S., Rajpoot, Sajjan, Saqib, Uzma, Takasaki, Tomohiko, Hara, Yukihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278780/
https://www.ncbi.nlm.nih.gov/pubmed/35830431
http://dx.doi.org/10.1371/journal.pone.0271112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278780/
https://www.ncbi.nlm.nih.gov/pubmed/35830431
http://dx.doi.org/10.1371/journal.pone.0271112

Ejemplares similares